These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 30536446)

  • 1. Antiresorptive agents' bone-protective and adjuvant effects in postmenopausal women with early breast cancer.
    Chukir T; Liu Y; Farooki A
    Br J Clin Pharmacol; 2019 Jun; 85(6):1125-1135. PubMed ID: 30536446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Options for the Management of Aromatase Inhibitor- Associated Bone Loss.
    Gaudio A; Xourafa A; Rapisarda R; Castellino P
    Endocr Metab Immune Disord Drug Targets; 2022; 22(3):259-273. PubMed ID: 34370654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
    Ito K; Blinder VS; Elkin EB
    J Clin Oncol; 2012 May; 30(13):1468-75. PubMed ID: 22370313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Treatment-Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy.
    Diana A; Carlino F; Giunta EF; Franzese E; Guerrera LP; Di Lauro V; Ciardiello F; Daniele B; Orditura M
    Curr Treat Options Oncol; 2021 Apr; 22(5):45. PubMed ID: 33864145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Denosumab versus zoledronic acid to prevent aromatase inhibitors-associated fractures in postmenopausal early breast cancer; a mixed treatment meta-analysis.
    Abdel-Rahman O
    Expert Rev Anticancer Ther; 2016 Aug; 16(8):885-91. PubMed ID: 27210216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer.
    Candelaria-Quintana D; Dayao ZR; Royce ME
    Breast Cancer Res Treat; 2012 Apr; 132(2):355-63. PubMed ID: 21987034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results.
    Nakatsukasa K; Koyama H; Ouchi Y; Ono H; Sakaguchi K; Matsuda T; Kato M; Ishikawa T; Yamada K; Yoshimura M; Koizumi K; Sakurai T; Shigematsu H; Takahashi S; Taira S; Suzuki M; Narui K; Niikura N; Hasegawa Y; Miura D; Konishi E; Taguchi T;
    Breast Cancer; 2019 Jan; 26(1):106-112. PubMed ID: 30054855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of bone health in postmenopausal women on aromatase inhibitors (AIs): a single health care system experience.
    Tremblay D; Patel V; Fifer KM; Caro J; Kolodka O; Mandelli J; Shapiro CL
    Support Care Cancer; 2018 Jan; 26(1):197-202. PubMed ID: 28744736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in Preventing Bone Loss Induced by Aromatase Inhibitors.
    Rachner TD; Göbel A; Jaschke NP; Hofbauer LC
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32674135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
    Sidhu HK
    Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for the efficacy of denosumab in postmenopausal Japanese women with non-metastatic breast cancer receiving adjuvant aromatase inhibitors: a combined analysis of two prospective clinical trials.
    Nakatsukasa K; Koyama H; Ouchi Y; Sakaguchi K; Fujita Y; Matsuda T; Kato M; Konishi E; Taguchi T
    J Bone Miner Metab; 2019 Sep; 37(5):864-870. PubMed ID: 30868270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials.
    Bassatne A; Bou Khalil A; Chakhtoura M; Arabi A; Van Poznak C; El-Hajj Fuleihan G
    Metabolism; 2022 Mar; 128():154962. PubMed ID: 34958816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical benefits of bone targeted agents in early breast cancer.
    Coleman R
    Breast; 2019 Nov; 48 Suppl 1():S92-S96. PubMed ID: 31839171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors.
    Gonzalez-Rodriguez E; Aubry-Rozier B; Stoll D; Zaman K; Lamy O
    Breast Cancer Res Treat; 2020 Jan; 179(1):153-159. PubMed ID: 31598815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic approaches for protecting bone health in patients with breast cancer.
    Lüftner D; Niepel D; Steger GG
    Breast; 2018 Feb; 37():28-35. PubMed ID: 29073497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of denosumab administration on low bone mineral density (T-score -1.0 to -2.5) in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer.
    Nakatsukasa K; Koyama H; Ouchi Y; Sakaguchi K; Fujita Y; Matsuda T; Kato M; Konishi E; Taguchi T
    J Bone Miner Metab; 2018 Nov; 36(6):716-722. PubMed ID: 29116414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing Bone Health in Breast Cancer.
    Kearns AE
    Endocr Pract; 2023 May; 29(5):408-413. PubMed ID: 36509360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics.
    Popp AW; Zysset PK; Lippuner K
    Osteoporos Int; 2016 May; 27(5):1917-21. PubMed ID: 26694598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab: A Review in Postmenopausal Osteoporosis.
    Deeks ED
    Drugs Aging; 2018 Feb; 35(2):163-173. PubMed ID: 29435849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
    Brufsky A
    Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.